{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:30:01Z","timestamp":1791041401926,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:italic>De novo<\/jats:italic> inflammatory bowel disease (IBD) in response to rituximab (RTX) has been documented on multiple occasions as a severe adverse effect. However, none of these reports mentioned any genetic variation associated with this complication. We describe the case of a 16-year-old patient with refractory nephrotic syndrome (NS) diagnosed at the age of 6 years, notably with a heterozygous mutation of the <jats:italic>ATG2A<\/jats:italic> gene, who developed Crohn's disease (CD) following ten administrations of RTX. Seventy months after the first and 6 months after the last RTX dose, the patient developed recurrent abdominal pain, hematochezia, oral aphthous ulcers and weight loss. On the basis of clinical evaluation and ileo-colonoscopy findings, the patient was diagnosed with CD and treated with mesalazine. A significant amelioration of clinical symptoms was achieved after 11 days of mesalazine treatment. A repeat ileo-colonoscopy performed 4 months later revealed near-complete resolution of the ulcers and marked mucosal healing. The underlying pathophysiology of RTX-induced IBD has not yet been clarified. Autophagy associated with <jats:italic>ATG2A<\/jats:italic> mutation is likely involved in the pathogenesis. This case underscores the need for vigilance in monitoring children with NS with gastrointestinal symptoms following RTX treatment, especially those who have hereditary susceptibility and have received multiple administrations.<\/jats:p>","DOI":"10.3389\/fped.2024.1464757","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T04:38:04Z","timestamp":1732077484000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Crohn's disease after multiple doses of rituximab treatment in a child with refractory nephrotic syndrome and an ATG2A mutation: a case report"],"prefix":"10.3389","volume":"12","author":[{"given":"Kaili","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengkun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2215\/CJN.08570722","article-title":"Use of rituximab in childhood idiopathic nephrotic syndrome","volume":"18","author":"Chan","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1681\/ASN.2021111472","article-title":"Long-term efficacy and safety of repeated rituximab to maintain remission in idiopathic childhood nephrotic syndrome: an international study","volume":"33","author":"Chan","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.3390\/jcm9062013","article-title":"Genetic study in Korean pediatric patients with steroid-resistant nephrotic syndrome or focal segmental glomerulosclerosis","volume":"9","author":"Park","year":"2020","journal-title":"J Clin Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.1007\/s11033-021-06711-4","article-title":"Mutational landscape of TRPC6, WT1, LMX1B, APOL1, PTPRO, PMM2, LAMB2 and WT1 genes associated with steroid resistant nephrotic syndrome","volume":"48","author":"Thakor","year":"2021","journal-title":"Mol Biol Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1093\/ndt\/gfp266","article-title":"Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment","volume":"24","author":"Soliman","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B6","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00467-023-06124-4","article-title":"Efficacy and safety of long-term repeated use of rituximab in pediatric patients with nephrotic syndrome","volume":"39","author":"Choi","year":"2024","journal-title":"Pediatr Nephrol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/MPG.0000000000002454","article-title":"Texture analysis of magnetic resonance enterography contrast enhancement can detect fibrosis in Crohn disease strictures","volume":"69","author":"Tabari","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6935","DOI":"10.3390\/ijms25136935","article-title":"The diagnosis of intestinal fibrosis in Crohn's disease-present and future","volume":"25","author":"Jarmakiewicz-Czaja","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41575-024-00935-y","article-title":"A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn\u2019s disease in clinical practice","volume":"21","author":"Bettenworth","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1148\/radiol.2017171221","article-title":"Characterization of degree of intestinal fibrosis in patients with Crohn disease by using magnetization transfer MR imaging","volume":"287","author":"Li","year":"2018","journal-title":"Radiology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3348\/kjr.2019.0217","article-title":"Comparison of three magnetization transfer ratio parameters for assessment of intestinal fibrosis in patients with Crohn\u2019s disease","volume":"21","author":"Meng","year":"2020","journal-title":"Korean J Radiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.crohns.2011.06.008","article-title":"Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn\u2019s disease patients","volume":"6","author":"Brinar","year":"2012","journal-title":"J Crohns Colitis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1167741","DOI":"10.3389\/fimmu.2023.1167741","article-title":"State of the art in childhood nephrotic syndrome: concrete discoveries and unmet needs","volume":"14","author":"Vincenti","year":"2023","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.ekir.2023.05.022","article-title":"Long-term efficacy and safety of rituximab versus tacrolimus in children with steroid dependent nephrotic syndrome","volume":"8","author":"Basu","year":"2023","journal-title":"Kidney Int Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e243","DOI":"10.1542\/peds.2009-3395","article-title":"Severe ulcerative colitis after rituximab therapy","volume":"126","author":"Ardelean","year":"2010","journal-title":"Pediatrics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1007\/s00467-023-06021-w","article-title":"An unusual cause of diarrhea in a child with nephrotic syndrome: answers","volume":"38","author":"Baltu","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13730-018-0364-8","article-title":"Crohn\u2019s disease following rituximab treatment in a patient with refractory nephrotic syndrome","volume":"8","author":"Morita","year":"2019","journal-title":"CEN Case Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e15285","DOI":"10.1111\/ped.15285","article-title":"Rituximab-induced Crohn\u2019s disease in a child with refractory nephrotic syndrome","volume":"64","author":"Machida","year":"2022","journal-title":"Pediatr Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","article-title":"Crohn\u2019s disease","volume":"6","author":"Roda","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/00365521.2020.1854847","article-title":"Increased risk of inflammatory bowel disease among patients treated with rituximab in Iceland from 2001 to 2018","volume":"56","author":"Kristj\u00e1nsson","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ajpath.2010.10.022","article-title":"IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model","volume":"178","author":"Yanaba","year":"2011","journal-title":"Am J Pathol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4143\/crt.2020.406","article-title":"Crohn\u2019s disease following rituximab treatment for follicular lymphoma in a patient with synchronous gastric signet ring cells carcinoma: a case report and literature review","volume":"52","author":"Cavalcanti","year":"2020","journal-title":"Cancer Res Treat"},{"key":"B23","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2169\/internalmedicine.5119-20","article-title":"Rituximab-induced ileocolitis in a patient with gastric MALToma: a case report and literature review","volume":"60","author":"Tsuzuki","year":"2021","journal-title":"Intern Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"108916","DOI":"10.1016\/j.clim.2021.108916","article-title":"Therapeutic agents affecting the immune system and drug-induced inflammatory bowel disease (IBD): a review on etiological and pathogenetic aspects","volume":"234","author":"Del Sordo","year":"2022","journal-title":"Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"645500","DOI":"10.3389\/fmicb.2021.645500","article-title":"Lactobacillus reuteri alleviates gastrointestinal toxicity of rituximab by regulating the proinflammatory T cells in vivo","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Microbiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1187911","DOI":"10.3389\/fphar.2023.1187911","article-title":"Preclinical evidence of probiotics in ulcerative colitis: a systematic review and network meta-analysis","volume":"14","author":"Jin","year":"2023","journal-title":"Front Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1016\/j.molcel.2022.10.017","article-title":"ATG9A and ATG2A form a heteromeric complex essential for autophagosome formation","volume":"82","author":"van Vliet","year":"2022","journal-title":"Mol Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/15548627.2021.1909406","article-title":"How autophagy controls the intestinal epithelial barrier","volume":"18","author":"Foerster","year":"2022","journal-title":"Autophagy"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3390\/cells12131779","article-title":"Autophagy in Crohn\u2019s disease: converging on dysfunctional innate immunity","volume":"12","author":"Alula","year":"2023","journal-title":"Cells"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1038\/s41598-018-23065-3","article-title":"Autophagy maintains stem cells and intestinal homeostasis in Drosophila","volume":"8","author":"Nagy","year":"2018","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.3390\/jcm13071888","article-title":"The role of TNF-\u03b1 in the pathogenesis of idiopathic nephrotic syndrome and its usefulness as a marker of the disease course","volume":"13","author":"Pukaj\u0142o-Marczyk","year":"2024","journal-title":"J Clin Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1464757\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T04:38:07Z","timestamp":1732077487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1464757\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":32,"alternative-id":["10.3389\/fped.2024.1464757"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1464757","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"article-number":"1464757"}}